Your search returned 63 results.

Results
	61.	A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors. [electronic resource] by Grilley-Olson, J E Bedard, P L Fasolo, A Cornfeld, M Cartee, L Razak, A R Abdul Stayner, L-A Wu, Y Greenwood, R Singh, R Lee, C B Bendell, J Burris, H A Del Conte, G Sessa, C Infante, J R Producer: 20180104 In: Investigational new drugs vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	62.	Reliability of diagnosis from Mohs slides: interpersonal and intrapersonal agreement on basal cell carcinoma presence and histological subtype. [electronic resource] by van Lee, C B Ip Vai Ching, E E F Nasserinejad, K Neumann, H A M Bol, M G W Dikrama, P K Kelleners-Smeets, N W J Koljenović, S Munte, K Noordhoek Hegt, V de Vijlder, H C Nijsten, T van den Bos, R R Producer: 20170815 In: The British journal of dermatology vol. 175 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	63.	Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors. [electronic resource] by Hellmann, M D Kim, T-W Lee, C B Goh, B-C Miller, W H Oh, D-Y Jamal, R Chee, C-E Chow, L Q M Gainor, J F Desai, J Solomon, B J Das Thakur, M Pitcher, B Foster, P Hernandez, G Wongchenko, M J Cha, E Bang, Y-J Siu, L L Bendell, J Producer: 20200623 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)